Compounds > fluocortolone
Page last updated: 2024-08-20

fluocortolone and cyclosporine

fluocortolone has been researched along with cyclosporine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Marzio, P; Giordano, M; Morelli, S; Priori, R; Sgreccia, A; Valesini, G1
Aresu, G; Barca, L; Frongia, T; Pascalis, L; Pia, G1
Aresu, G; Ledda, MA; Pascalis, L; Pia, G; Rosetti, L1
Favre, H; Lemoine, R; Miescher, PA; Tamagnini, P1
Althaus, C; Hillenkamp, J; Kersten, A; Sundmacher, R1
Gonzales, S; Manzotti, F; Orsoni, JG; Zavota, L1

Trials

1 trial(s) available for fluocortolone and cyclosporine

ArticleYear
Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis.
    Journal of autoimmunity, 1993, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Autoimmune Diseases; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Fluocortolone; Humans; Male; Methotrexate; Middle Aged; Uveitis; Visual Acuity

1993

Other Studies

5 other study(ies) available for fluocortolone and cyclosporine

ArticleYear
Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus.
    Lupus, 1993, Volume: 2, Issue:6

    Topics: Adult; Blood Pressure; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Echocardiography, Doppler; Female; Fluocortolone; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Pulmonary Artery

1993
Evaluation of the efficacy and toxicity of the cyclosporine A-flucortolone-methotrexate combination in the treatment of sarcoidosis.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 1996, Volume: 13, Issue:2

    Topics: Adult; Aged; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluocortolone; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Methotrexate; Middle Aged; Peptidyl-Dipeptidase A; Radioimmunoassay; Remission Induction; Sarcoidosis, Pulmonary; Treatment Outcome

1996
Drug-combination therapy of rheumatoid arthritis.
    Springer seminars in immunopathology, 1998, Volume: 20, Issue:1-2

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Fluocortolone; Glucocorticoids; Humans; Kidney; Longitudinal Studies; Male; Methotrexate; Middle Aged

1998
[Cyclosporin A therapy in severe anterior scleritis. 5 severe courses without verification of associated systemic disease treated with cyclosporin A].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2000, Volume: 97, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluocortolone; Humans; Male; Recurrence; Scleritis; Treatment Outcome

2000
Syphilitic interstitial keratitis: treatment with immunosuppressive drug combination therapy.
    Cornea, 2004, Volume: 23, Issue:5

    Topics: Child; Corneal Stroma; Cyclosporine; Drug Therapy, Combination; Eye Infections, Bacterial; Fluocortolone; Glucocorticoids; Humans; Immunosuppressive Agents; Keratitis; Male; Syphilis Serodiagnosis; Syphilis, Congenital

2004